We further assessed the anti-tumor effects of JAK2/STAT3 inhibitor and MEK inhibitor as single agents and in various combinations in K-Ras mutated pancreatic and colon cells in vitro, as well as nude mice tumor model in vivo. Here, KRAS is linked to neoplasm.